Delivery Order SPE2DB22D3301-SPE2DB26FX4KE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on July 21, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Yonsa (abiraterone acetate) is a specialized pharmaceutical used in the treatment of prostate cancer, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Yonsa (abiraterone acetate) 125 mg tablets in a quantity of 120 units, with a ceiling value of $4,542.74 and completion date of July 11, 2025. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a $11,356.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on September 16, 2025, with an ultimate completion date of October 7, 2025. This non-competitive delivery order was placed against AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $4,542.74 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of 120 tablets of Yonsa 125 mg, with performance completion targeted for August 22, 2025. This firm fixed-price contract was awarded without set-aside designation through open competition and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Yonsa is a prescription medication used in oncology treatment, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,271.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on October 20, 2025, with an ultimate completion date of November 10, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime contract serves as a comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Yonsa 125 mg tablets in a quantity of 120 units, with a ceiling value of $9,085.44. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract is scheduled for ultimate completion by October 21, 2025, and will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on June 4, 2025, with completion expected by June 26, 2025. This firm fixed-price contract is a non-competitive child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg, a pharmaceutical product used in cancer treatment. The contract is firm fixed price with no set-aside designation and was competitively awarded on October 28, 2025, with an ultimate completion date of November 19, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Yonsa 125 mg tablets (120-count units) valued at $2,271.36 with a firm fixed price structure. The order is scheduled for completion by May 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a delivery order under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Yonsa 125 mg tablets (120 count). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by September 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX4KEDelivery Order
The Defense Logistics Agency awarded a $18.17K delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Yonsa 125 mg tablets (120-count units). This firm fixed-price, non-set-aside contract will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of November 28, 2025. Yonsa (abiraterone acetate) is a prescription medication used in the treatment of castration-resistant prostate cancer, representing the type of specialized pharmaceutical product that AmerisourceBergen supplies to support federal military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99M ceiling value and extends through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support across multiple therapeutic domains and enables the company to deliver brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency programs, the U.S. Coast Guard, and other federal healthcare systems worldwide. The competitively awarded IDC demonstrates AmerisourceBergen's established capacity to fulfill complex federal medical supply requirements at scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.2k | 11/5/25 |